Neovision Capital

Chengdu New Radiomedicine Technology Co.,Ltd. is a Chinese medical isotopes provider. Our business covers research, manufacture and sales for medical isotopes and products. We provide services for malignant tumor diagnosis and treatments and radionuclides medicine technology support and consulting. In April 2016, the company was founded by three co-founders experienced in radionuclides research and development. Jihui Qian, former President of Nuclear Power Institute of China (NPIC), former Deputy Director-General of International Atomic Energy Agency (IAEA); Maoliang Li, former Director of Chengdu Isotopes Institute of NPIC; and Jiming Cai, former Vice President of Sichuan Institute of Atomic Energy. The company is located in Western Airport Development District, Shuangliu, Chengdu, with an area of 71 Are, registered capital of 32.83 million CNY, and total investment of 300 million CNY. The project is listed as "Annual Key Investment Projects of Sichuan Province and Chengdu City in 2017, 2018 and 2019". At present, the company has over 80 employees, with more than 60 R&D specialists, including 1 academician of Chinese Academy of Engineering, 2 experts of Thousand Talent Project, 2 academic and technical leaders from Sichuan province, 10 researchers (associate researchers), and more than 20 people with middle or senior titles. Among them, there are 6 PhDs and over 30 graduates. The proportion of R&D staff has reached 70%, making CNRT the most innovative technology enterprise in the radiopharmaceutical industry in China.

Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Shanghai Electric Group Corp is a Chinese company specializing in the design, development, and manufacturing of thermal, nuclear, and wind power equipment. They provide a wide range of products including gas turbines, transmission and distribution equipment, elevators, machine tools, refrigeration compressors, environmental protection equipment, automation products, rail transportation equipment, machine parts, generators, and more. With a focus on power generation and infrastructure, Shanghai Electric Group Corp plays a significant role in China's energy sector and transportation industry.

Care Medical is a membrane science platform that focuses on blood purification and biopharmaceuticals.

Media Center is a technology-based corporation that uses technological innovation to boost industrial upgrading. It enables biotechnology and the bioindustry, the employs automation, artificial intelligence, big data, and industrial Internet technologies. Robot scientists free human scientists' hands, unleash their creativity, and raise the time and life value of mental workers, intelligent parallel bioreactors accelerate the R&D cycle, save laboratory space, and reduce R&D costs.

Zhongbo Ruikang focuses on the research and development of domestic tools in the field of cell and gene therapy, mainly to assist customers in realizing the "continuous, closed, disposable, consistent, scalable, automated, modular, and medical deviceization of cell preparation industrialization.

Dakang Medical operates a network of independent medical facilities specializing in blood purification services for kidney disease. The company focuses on providing advanced treatments such as hemodialysis, hemofiltration, and peritoneal dialysis, utilizing state-of-the-art medical technology. Dakang Medical emphasizes a patient-centered approach, aiming to create a warm and supportive environment to enhance the treatment experience for individuals suffering from nephropathy. In addition to its clinical services, Dakang Medical is involved in medical investment and the management of medical institutions, as well as offering brand operation services within the healthcare sector.

Xingsai Bio is a developer of single-cell analysis instruments and supporting reagents and consumables.

Maibang Bio provides biomedical process solutions such as R&D and production, customized medium optimization and development services, and liquid medium production. Their cell-culture medium companies might benefit from product performance and optimization development services. Maibang Bio focuses on the development and production of high-end chemically defined media products, the optimized development of customized media services, large-scale dry powder/liquid medium production, and other comprehensive biomedical process solutions.

Nuoyuan Medical is a developer of advanced medical devices that specializes in precision tumor surgery and treatment technology. The company aims to enhance clinical outcomes and optimize resource utilization in healthcare settings. By focusing on innovative solutions, Nuoyuan Medical significantly improves the efficiency of medical professionals while delivering effective treatment options for patients dealing with tumors.

RzonTech is a provider of industrial software products, data services, and overall solutions.

Matrixtime Robotics, founded in 2018 and based in Hongqiao, China, specializes in the development of deep learning and robot vision technology. The company creates advanced artificial intelligence systems designed for industrial applications, enabling factories and manufacturers to enhance their production processes. Matrixtime's offerings include solutions for defect detection, item picking, sorting, and complex machine vision inspection, serving various sectors such as semiconductor manufacturing, photovoltaic energy, automotive precision manufacturing, and unmanned ports. By integrating sophisticated deep learning algorithms into its robotic systems, Matrixtime aims to empower high-end manufacturing and facilitate digital transformation within the industry, ultimately improving production efficiency and reducing quality assurance costs.

Xgene Pharmaceutical Inc. is a late-clinical stage pharmaceutical company established in 2015, based in the Cayman Islands. It focuses on developing small-molecule drugs aimed at treating chronic pain, infectious diseases, and tumors. Utilizing proprietary linker technology, Xgene creates novel, multimodal conjugated molecules that enhance the efficacy and tolerability of pain medications. The company's current programs are dedicated to addressing unmet needs in neurological disorders, making significant strides in the development of innovative treatments for these conditions.

Chineo is a provider of CAR-T immune cell therapy services, specializing in the research and development of innovative cell therapy products aimed at treating tumors and immune diseases. The company focuses on tumor infiltrating lymphocyte therapy (TIL) by integrating high-throughput gene sequencing with CAR-T and other advanced cell therapy technologies. This approach enhances the ability of medical practitioners to diagnose and treat tumors more effectively, contributing to advancements in cancer therapy.

Andisec is dedicated to the research and development of industrial network security technology, products, and services. The company specializes in creating software designed to identify and defend against cyber attacks, viruses, and other cybersecurity threats. By enhancing the security of network systems, Andisec enables industrial enterprises to operate more securely, thereby safeguarding their critical infrastructure and data from potential breaches.

Rimag is a Shenzhen-based company specializing in medical imaging services. Founded in 2014, it operates medical imaging centers that provide examination and diagnostic services, including MRI, CT, PET, X-ray, ultrasound, and mammography. In addition to its imaging center operations, Rimag is involved in the development of relevant cloud technology and the training of professionals in the field. The company generates revenue through its comprehensive range of services, including Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services.

Shenzhen MicroApproach Medical Technology Co., Ltd., established in September 2015, focuses on the research, manufacture, and sale of endovascular medical devices. Recognized as a high-tech enterprise, the company specializes in interventional surgery consumables, including hydrophilic guide wires, ultra-smooth guide wires, and angiography catheters. MicroApproach has formed strong research collaborations with prominent institutions like Beijing Tiantan Hospital and the People's Liberation Army 301 Hospital, enhancing its research and development capabilities. The company emphasizes quality and innovation, striving to provide first-class products for medical professionals and patients while contributing to the advancement of endovascular intervention technologies in China. To support large-scale production, MicroApproach has implemented a comprehensive management system and established a state-of-the-art industrial production line specifically for hydrophilic coating guide wires.

Jiangsu Hualan New Pharmaceutical Material Co., Ltd. specializes in the development, manufacture, and distribution of pharmaceutical packaging materials, primarily serving the Asia-Pacific region. The company produces a variety of products, including butyl rubber stoppers for transfusion, lyophilized and sterile powder applications, blood collection systems, and various types of containers such as three-piece soft bags and plastic bottles. Additionally, Hualan offers components like butyl compound films and gaskets. Established in 1992 and based in Jiangyin, China, the company was formerly known as Jiangyin Lanling Bottle Stopper Co., Ltd. It focuses on providing high-quality packaging solutions that ensure the safety and efficacy of pharmaceutical products.

Hocermed is a provider of energy platforms for invasive surgery. They has established research and development bases. They creates a comprehensive system that supports research and development, quality control, production, sales, and service. They supplies products with minimally invasive surgical solutions to healthcare professionals. They also invasive surgical energy devices. They provides surgical products and services to surgeons.

Hangzhou Proprium Biotech Company Limited is engaged in the development, manufacture, and sale of biomedical products and diagnostic reagents focused on cancer and cardiovascular diseases. The company provides a range of cardiac markers for heart disease diagnosis, including NT-proBNP and cTnI, as well as cirrhosis markers for liver disease, such as Fibro-CHI diagnostic kits. Proprium also offers various diagnostic tools, including rapid immunoassay readers, colloidal gold kits, enzyme-linked immunosorbent assay kits, and polymerase chain reaction detection kits. Additionally, the company has developed a mobile application aimed at managing liver diseases. Established in 2010 and based in Hangzhou, China, Proprium is committed to enabling early disease detection for improved patient outcomes.

Allist Pharmaceuticals is a pharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, particularly in the area of cancer treatment. The company addresses unmet clinical needs within the global pharmaceutical market, emphasizing the importance of scientific and technological advancements to improve patient outcomes. Allist Pharmaceuticals is committed to creating safe and effective drugs that are backed by independent intellectual property rights, ensuring that their innovative therapies can meet the diverse needs of patients.

Shanghai Smartee Denti-Technology Co. Ltd is a company specializing in the development of an invisible orthodontic system, including a transparent aligner designed to move teeth into the desired position with precision. Founded in 2004 by a team of experts, including those with international experience and renowned orthodontics professionals, the company operates from the Shanghai Zhangjiang Hi-Tech Park. Smartee integrates advanced technologies such as 3D printing, computer-aided design (CAD), and digital modeling (CAM) to create aligners that are free from arch wires and brackets, making them safe for the oral cavity and easy to remove for eating and hygiene. The company collaborates with prominent research institutions, leveraging their expertise to enhance its digital orthodontic technology and has developed proprietary invisible appliance technology, which has received national accolades and patent protection for its innovative approach in orthodontics.

Beijing Biostar Technologies, Ltd. is a biotechnology company based in Beijing, China, founded in 2002. The company specializes in the development of anti-tumor chemotherapy biopharmaceuticals, focusing on the innovation and formulation of small molecule chemical drugs for cancer treatment. Led by a team of Chinese scientists, Biostar engages in biomedical development and technology transfer, offering technical service consulting as part of its operations. The company is recognized for its pioneering work in creating new anti-cancer drugs, including the development of epothilone, and its technologies are considered to be at an internationally advanced level.

Rimag is a Shenzhen-based company specializing in medical imaging services. Founded in 2014, it operates medical imaging centers that provide examination and diagnostic services, including MRI, CT, PET, X-ray, ultrasound, and mammography. In addition to its imaging center operations, Rimag is involved in the development of relevant cloud technology and the training of professionals in the field. The company generates revenue through its comprehensive range of services, including Imaging Center Services, Imaging Solution Services, and Rimag Cloud Services.

PANDAINS is an automobile insurance platform.

Automobile insurance sales management platform.

PANDAINS is an automobile insurance platform.

ACROBiosystems Inc. specializes in the manufacture of recombinant proteins for oncological treatments, particularly in the field of cancer immunotherapy. Founded in 2013 and based in Newark, Delaware, the company offers a diverse range of products, including immune checkpoint proteins, targets for CAR-T cell therapy, biosimilar drug targets, and various recombinant proteins such as cytokines and enzymes. Additionally, ACROBiosystems provides pre-labeled proteins, including biotinylated and heavy-labeled collections, as well as kits for quantitative analysis of therapeutic antibodies and inhibitor screening. The company also develops recombinant antigens for SARS-CoV-2 variants and adheres to GMP quality management standards for its cytokine products. ACROBiosystems is dedicated to supplying essential reagents and services necessary for the development of targeted therapeutic drugs.

Oranger is a developer of portable wearable medical devices aimed at treating chronic respiratory diseases, particularly sleep apnea. The company offers remote management services that facilitate diagnosis and treatment at home. Utilizing a cloud-based interactive platform, Oranger provides comprehensive medical services, including screening, clinical evaluation, personalized treatment, and follow-up examinations. This approach empowers patients to effectively manage their conditions and supports their rehabilitation from chronic respiratory illnesses.

Boke Information Co., Ltd. specializes in the research and development of management software and offers management consultancy services in China. The company focuses on creating logistics management solutions that enhance supply chain efficiency through the application of artificial intelligence and machine learning technologies. Boke provides implementation and maintenance services for its software products, catering to various enterprises, government entities, and community organizations. Its innovative approach emphasizes personalized software solutions designed for autonomous configuration, self-expansion, and autonomous maintenance. By supporting clients throughout the entire lifecycle of their IT systems, Boke assists in establishing comprehensive organizational frameworks and ecological structures tailored to their specific needs.

Shanghai Genext Medical Technology Co., Ltd specializes in the transplantation industry in China, offering a range of products and services that support organ transplants. Founded in 2003 and based in Shanghai, the company provides transplantation drugs, medical instruments, and in-vitro diagnostics. Its offerings include immunosuppressants, organ preservation and immune function platforms, therapeutic drug monitoring equipment, and various operational accessories. By focusing on innovative medical technologies, Shanghai Genext aims to enhance organ preservation, assessment, and diagnostic capabilities, ultimately delivering reliable and cost-effective medical services to patients. The company addresses diverse transplant needs, including kidney, heart, lung, bone marrow, and cell transplants.

RenRenChe, founded in April 2014, operates as a consumer-to-consumer (C2C) auto transaction service platform specializing in both used and new car sales. The company offers a range of services, including free door-to-door car valuation, sales, and replacement. To ensure quality, RenRenChe has established rigorous testing standards and employs a team of professional appraisers, collaborating with the China Automobile Dealers Association to set national benchmarks for second-hand car testing. The platform provides significant after-sales guarantees, including a 14-day return policy and a one-year warranty on core components, thereby enhancing buyer confidence. RenRenChe has attracted considerable investment, securing significant funding from notable investors, which has facilitated its growth and technological development within the industry.